A breakthrough for those with inoperable lung cancer.
Pharmac is funding a new immunotherapy medicine, called infensey for those with New Zealand's deadliest cancer.
It's the first medicine of its kind funded for lung cancer and will be available for anyone to access.
Lung Foundation CEO Philip Hope says this is a massive step forward in the fight against cancer.
He says the drug gives patients diagnosed with stage 3 non-small cell lung cancer a good option when undergoing treatment.
LISTEN ABOVE

Mark Wilshire: Co-operative Bank CEO ahead of the Official Cash Rate announcement
03:26

Bevan McKenzie: Health NZ Chief Financial Officer on the inquiry into the Manage My Health cyber-attack
04:48

Steve Cullen: Criminal Lawyer on 2025 remand numbers dropping as prisoner numbers reach record highs
02:33